Navigation Links
Bioenergy Introduces Corvalen M(R) as a Natural Treatment Option for Fibromyalgia Symptoms
Date:5/27/2010

MINNEAPOLIS, May 27 /PRNewswire/ -- Fibromyalgia affects as many as one in 50 Americans, 90 percent of whom are women. Yet, despite its nearly epidemic status, patients still often rely on pharmaceutical options solely for treatment. That's why Bioenergy Life Science, Inc. (www.bioenergy.com) has introduced Corvalen M®, a natural treatment option for fibromyalgia symptoms.  

Fibromyalgia is a syndrome mainly associated with widespread muscular pains and fatigue. The exact causes of fibromyalgia are unknown; however, patients with fibromyalgia have been shown to have an alteration in muscle adenine nucleotide metabolism, leading to depleted energy reserves (1).  As an essential compound in increasing muscular energy pools and reducing metabolic strain in affected muscles, Corvalen M® has been shown to be effective against fibromyalgia symptoms (2).

Corvalen M® comprises D-Ribose, a simple, 5-carbon monosaccharide, or pentose sugar. D-Ribose helps accelerate the formation of adenosine triphosphate (ATP), the primary energy source of all living cells, which can lead to subsequent tissue recovery for fibromyalgia patients.

"Having had Chronic Fatigue Syndrome and Fibromyalgia back in 1975, I know what patients are going through," says Dr. Jacob Teitelbaum, M.D, one of the primary researchers of this study and the medical director of the Fibromyalgia and Fatigue Centers, Inc. "The good news is these illnesses have become very treatable!"

Teitelbaum conducted a multi-center study, in which 53 health practitioners enrolled 257 patients who had been diagnosed with fibromyalgia and/or chronic fatigue syndrome. Each patient was given D-Ribose (Corvalen) at a dose of five grams per day for three weeks. All patients were measured for changes in energy, sleep, cognitive function, pain and overall well-being.

Teitelbaum noted improvement in the first week of treatment. After three weeks, results showed statistically significant improvements in all five parameters, More than half of the study's patients showed improvement in energy (61 percent), followed by a 37 percent increase in overall well-being.  

Bioenergy Life Science, Inc. focuses its core technology on D-Ribose®, the primary ingredient in the Corvalen Medical Food family of products, which include Corvalen®, Corvalen M® and Corvalen® Chewable Wafers. D-Ribose® is the only ribose to receive GRAS (generally regarded as safe) affirmation, no questions letter from the Food and Drug Administration (FDA). D-Ribose® is found also in many energy drinks, bars and supplements.

For more information, contact Renee Cooper of Christie Communications at 805-969-3744 or rcooper@christiecomm.com.

(1)  Gebhart B, Jorgenson JA. Benefit of ribose in a patient with fibromyalgia. Pharmacotherapy. 2004 Nov;24(11):1646-8

(2)  Teitelbaum J, Johnson C, Cyr J. The Use of D-Ribose in Chronic Fatigue Syndrome and Fibromyalgia: A Pilot Study. The Journal of Alternative and Complementary Medicine. 2006 12(9):857-862


'/>"/>
SOURCE Bioenergy Life Science, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Bersin & Associates Introduces New Talent Management Framework
2. Varian Medical Systems Introduces ProBeam(TM) Proton Therapy Platform at Particle Therapy Co-operative Group (PT COG) 2010 Meeting
3. Ambry Genetics Introduces AmbryScreen(TM), a Genetic Test Screening for Some of the Most Common and Severe Genetic Disorders Affecting Newborns.
4. Ethicon Endo-Surgery Introduces Two New Staplers for Open Surgical Procedures at ASCRS
5. Biosense Webster Introduces the THERMOCOOL(R) SF Irrigated Catheter in the European Union
6. Ethicon Endo-Surgery Introduces HARMONIC FOCUS(R) Long Curved Shears for Deep Surgical Access
7. MAQUET Cardiovascular Introduces New VASOSHIELD Pressure Controlling Syringe to Help Preserve Graft Integrity for Coronary Artery Bypass Surgery Patients
8. Burton Medical Introduces the AIM-200(R) as a Versatile, Long-Lasting Light Source for Ambulatory Surgical Centers
9. Sikorsky Global Helicopters Introduces State-of-the-Art Emergency Medical Services Interior for S-76(R) Helicopter
10. Samplify Introduces New Compression Technology to Lower Costs for Mobile Operators Migrating to 4G
11. Bayer Diabetes Care Introduces DIDGET In the US
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2017)... Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today announced financial ... 2017, and updated its financial outlook for fiscal 2017. ... fiscal third quarter, Hill-Rom reported earnings of $0.09 per ... the prior-year period. These results reflect after-tax special items, ... related to the non-cash write-down of assets associated with ...
(Date:7/27/2017)... Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results ... reported second quarter net sales of $1.954 billion, an ... an increase of 2.1% on a constant currency basis.  ... LDR Holding Corporation acquisition, second quarter 2017 revenues decreased ... on a constant currency basis. ...
(Date:7/26/2017)... 26, 2017 E.I. Medical Imaging (EIMI) has ... SharkLab to custom design the worlds first ultrasound system to be ... their native habitat. In preparation for a piece produced by ... Shark Week, Dr. Guttridge approached EIMI with the idea of ... to hammerhead sharks underwater. ...
Breaking Medicine Technology:
(Date:8/20/2017)... ... ... Are you an adult with gluten intolerance or Celiac disease living with another ... in a research study that focuses on family interactions when dealing with dietary restrictions. ... of adults who have gluten sensitivities who cohabitate with other adults who may or ...
(Date:8/19/2017)... ... August 19, 2017 , ... The digital health and ... with pending recognition status from the Centers for Disease Control and Prevention (“CDC”) ... and live video conferencing. , The DPP resulted from clinical work conducted ...
(Date:8/19/2017)... ... August 19, 2017 , ... Physician Partners of ... location as an interventional pain management physician. He brings a wealth of pain ... migraine headaches, and significant experience in spinal cord stimulation for chronic pain. , ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... LLC (“Quick”), a highly specialized asset-light logistics provider of complex transport solutions ... definitive agreement to purchase Unitrans International Corporation, a division of Roadrunner Transportation ...
(Date:8/18/2017)... O'Fallon, MO (PRWEB) , ... August 18, 2017 , ... ... Charles County, is inaugurating a new charity drive to generate community support for efforts ... for research into cures and treatments for all types of cancer. , Each ...
Breaking Medicine News(10 mins):